LAKE ZURICH, Ill., Dec. 16, 2010 /PRNewswire/ -- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today the U.S.

LAKE ZURICH, Ill.--(BUSINESS WIRE)-- Fenwal Inc., a global leader specializing in separation technologies for blood and cell collection and therapy, announced today it has received clearance from the ...

LAKE ZURICH, Ill., Aug. 19 Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)-- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today it has received CE ...

Fenwal, a global medical technology company focused on improving blood collection, to ensure the availability, safety and effectiveness of blood components, received FDA clearance for wireless data ...

Fenwal, a Fresenius Kabi company, announced today it has received 60601-1 3rd edition certification for the Aurora™ plasmapheresis system designed for collection of plasma. 60601-1 3rd edition is the ...

The U.S. Food and Drug Administration has cleared for marketing a new source plasma collection system developed by Fenwal, Inc., the company announced today. Called the Aurora TM plasmapheresis system ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, announced ...

HemaTerra Technologies, provider of end-to-end operational software products to blood centers, announced that it will work with Fenwal Inc. to develop a companion product to HemaConnect, the ...

SecurityInfoWatch is the security industry's premier, trusted source for breaking news, in-depth reporting, product insights and expert analysis across physical and cybersecurity sectors.